AZ Liver Health

Institute for Liver Health is now AZ Liver Health

Institute for Liver Health is now AZ Liver Health

March 21, 2019 | By | News & Events

As you may have noticed, The Institute for Liver Health has undergone a name change and updated its name to Arizona Liver Health™. The change comes with our desire to serve more patients in Arizona and establish our practices among …

Liver Disease Diet From American Liver Foundation

Liver Disease Diet From American Liver Foundation

March 21, 2019 | By | News & Events

Content sourced from Liver Foundation.org A Healthy Diet, a Healthier Liver, a Healthier You So, what should you eat to ensure that your liver can function normally? If you’re a liver patient, your diet is adjusted to meet your individual …

Intercept’s Drug for NASH Performs Well Enough for FDA Submission

Intercept’s Drug for NASH Performs Well Enough for FDA Submission

February 25, 2019 | By | News & Events

Content sourced from HepMag.com A placebo-controlled study of obeticholic acid showed it improved liver fibrosis with no worsening of non-alcoholic steatohepatitis. An advanced trial of Intercept Pharmaceuticals’ experimental non-alcoholic steatohepatitis (NASH) treatment found it improved liver fibrosis with no worsening …

FibroScan after endoscopy found undiagnosed NAFLD, NASH

FibroScan after endoscopy found undiagnosed NAFLD, NASH

October 11, 2018 | By | News & Events

Article sourced from Zachry WM, et al. Abstract 27. Presented at: American College of Gastroenterology Annual Scientific Meeting; Oct. 5-10, 2018; Philadelphia. PHILADELPHIA — FibroScan screening for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis could significantly improve patient diagnosis and care, …

Liver Disease Researchers Struggle to Find Patients for Clinical Trials

Liver Disease Researchers Struggle to Find Patients for Clinical Trials

January 5, 2018 | By | News & Events

Content sourced from Hepmag.com As pharmaceutical companies race to develop treatments for NASH, they find one thing is missing: willing test subjects. As the rate of liver disease continues to rise along with the rate of obesity, more than a …